Tao Wei Kang - Net Worth and Insider Trading

Tao Wei Kang Net Worth

The estimated net worth of Tao Wei Kang is at least $22 Million dollars as of 2024-06-24. Tao Wei Kang is the senior management of Jiangsu Hengrui Pharmaceuticals Co Ltd and owns about 533,000 shares of Jiangsu Hengrui Pharmaceuticals Co Ltd (SHSE:600276) stock worth over $22 Million. Details can be seen in Tao Wei Kang's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Tao Wei Kang has not made any transactions after 2021-06-11 and currently still holds the listed stock(s).

Transaction Summary of Tao Wei Kang

To

Tao Wei Kang Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Tao Wei Kang owns 1 companies in total, including Jiangsu Hengrui Pharmaceuticals Co Ltd (SHSE:600276) .

Click here to see the complete history of Tao Wei Kang’s form 4 insider trades.

Insider Ownership Summary of Tao Wei Kang

Ticker Comapny Transaction Date Type of Owner
SHSE:600276 Jiangsu Hengrui Pharmaceuticals Co Ltd 2021-06-11 senior management

Tao Wei Kang Latest Holdings Summary

Tao Wei Kang currently owns a total of 1 stock. Tao Wei Kang owns 533,000 shares of Jiangsu Hengrui Pharmaceuticals Co Ltd (SHSE:600276) as of June 11, 2021, with a value of $22 Million.

Latest Holdings of Tao Wei Kang

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SHSE:600276 Jiangsu Hengrui Pharmaceuticals Co Ltd 2021-06-11 533,000 40.41 21,538,530

Holding Weightings of Tao Wei Kang


Tao Wei Kang Form 4 Trading Tracker

According to the SEC Form 4 filings, Tao Wei Kang has made a total of 5 transactions in Jiangsu Hengrui Pharmaceuticals Co Ltd (SHSE:600276) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Jiangsu Hengrui Pharmaceuticals Co Ltd is the sale of 88,833 shares on June 11, 2021, which brought Tao Wei Kang around $0.

Insider Trading History of Tao Wei Kang

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Tao Wei Kang Trading Performance

GuruFocus tracks the stock performance after each of Tao Wei Kang's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Tao Wei Kang is -4.45%. GuruFocus also compares Tao Wei Kang's trading performance to market benchmark return within the same time period. The performance of stocks bought by Tao Wei Kang within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Tao Wei Kang's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Tao Wei Kang

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -9.22 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -11.55 LIMIT LIMIT LIMIT LIMIT LIMIT

Tao Wei Kang Ownership Network

Ownership Network List of Tao Wei Kang

No Data

Ownership Network Relation of Tao Wei Kang

Insider Network Chart

Tao Wei Kang Owned Company Details

What does Jiangsu Hengrui Pharmaceuticals Co Ltd do?

Who are the key executives at Jiangsu Hengrui Pharmaceuticals Co Ltd?

Tao Wei Kang is the senior management of Jiangsu Hengrui Pharmaceuticals Co Ltd. Other key executives at Jiangsu Hengrui Pharmaceuticals Co Ltd include Directors & senior managers Zhang Lian Shan , senior management Sun Xu Gen , and senior management Yuan Kai Hong .

Jiangsu Hengrui Pharmaceuticals Co Ltd (SHSE:600276) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Jiangsu Hengrui Pharmaceuticals Co Ltd (SHSE:600276) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Jiangsu Hengrui Pharmaceuticals Co Ltd (SHSE:600276) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Jiangsu Hengrui Pharmaceuticals Co Ltd (SHSE:600276)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Jiangsu Hengrui Pharmaceuticals Co Ltd Insider Transactions

No Available Data

Tao Wei Kang Mailing Address

Above is the net worth, insider trading, and ownership report for Tao Wei Kang. Currently GuruFocus does not have mailing address information for Tao Wei Kang.

Discussions on Tao Wei Kang

No discussions yet.